ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,933Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 783

$822K Total Retail Price of All Prescriptions

Rank: 88 out of 783

555 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 555 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 555 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 11,704 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 653 542 1 1
LISINOPRIL 495 398 2 4
AMLODIPINE BESYLATE 479 434 3 5
TRAMADOL HCL 467 440 4 20
OMEPRAZOLE 461 391 5 6
SIMVASTATIN 412 379 6 3
FUROSEMIDE 282 247 7 7
PRAVASTATIN SODIUM 275 216 8 14
METFORMIN HCL 220 165 9 8
ETODOLAC 214 188 10 297
HYDROCHLOROTHIAZIDE 205 153 11 12
TRAZODONE HCL 199 155 12 39
LEVOFLOXACIN 194 149 13 75
CYMBALTA 193 122 14 35
CITALOPRAM HBR 183 159 15 19
GABAPENTIN 174 127 16 15
METOPROLOL SUCCINATE 173 160 17 13
CARVEDILOL 157 143 18 21
FENTANYL 154 124 S2 19 65
DONEPEZIL HCL 148 148 20 24
ATENOLOL 147 138 21 17
NEXIUM 147 121 21 28
METOPROLOL TARTRATE 140 99 23 9
ALENDRONATE SODIUM 137 135 24 25
LOSARTAN POTASSIUM 134 119 25 18
ATORVASTATIN CALCIUM 132 116 26 11
WARFARIN SODIUM 131 112 27 10
AZITHROMYCIN 131 119 27 41
CIPROFLOXACIN HCL 128 120 29 62
POTASSIUM CHLORIDE 128 127 29 16
LANTUS 128 92 29 38
FLUCONAZOLE 128 100 29 179
FENOFIBRATE 127 90 33 66
MIRTAZAPINE 125 125 34 52
HYDROCODONE-ACETAMINOPHEN 122 94 S3 35 2
POLYETHYLENE GLYCOL 3350 119 115 36 43
PANTOPRAZOLE SODIUM 110 86 37 30
TAMSULOSIN HCL 110 107 37 26
CELEBREX 108 91 39 93
PREDNISONE 107 85 40 36
FLUOXETINE HCL 103 95 41 45
ALLOPURINOL 102 84 42 31
SERTRALINE HCL 101 74 43 22
LOSARTAN-HYDROCHLOROTHIAZIDE 96 95 44 53
CEPHALEXIN 89 79 45 70
DOXYCYCLINE HYCLATE 88 79 46 112
GLYBURIDE 81 73 R 47 111
SPIRONOLACTONE 81 63 47 57
NABUMETONE 79 67 49 178
DIOVAN 75 57 50 49
CLOPIDOGREL 74 73 51 29
AMLODIPINE BESYLATE-BENAZEPRIL 72 72 52 83
CLONIDINE 71 69 53 254
AMOX TR-POTASSIUM CLAVULANATE 70 61 54 128
CYCLOBENZAPRINE HCL 70 41 R 54 63
ESCITALOPRAM OXALATE 68 49 56 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 60 57 33
MELOXICAM 67 43 57 37
METOCLOPRAMIDE HCL 66 33 59 121
KLOR-CON M20 64 62 60 48
CARBIDOPA-LEVODOPA 64 61 60 88
ISOSORBIDE MONONITRATE ER 62 61 62 40
SYNTHROID 61 61 63 47
INSULIN SYRINGE 61 47 63 82
BENAZEPRIL HCL 60 60 65 85
ROPINIROLE HCL 59 22 66 74
PLAVIX 58 57 67 51
ZETIA 57 53 68 80
GLIPIZIDE 57 53 68 71
OXYBUTYNIN CHLORIDE 56 42 70 96
NOVOLOG 55 37 71 81
GLIPIZIDE ER 53 53 72 84
DIOVAN HCT 52 45 73 94
SINGULAIR 52 45 73 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.